This presentation will allow the participant to integrate and build on the foundational tools presented in the two previous presentations, add to their opioid prescribing toolbox and build on their clinical knowledge to prescribe opioids to mitigate opioid harm focusing on specific special populations. Further, the participant will be exposed to clinical and social data as it appears in the literature to assist in understanding healthcare disparities in opioid prescribing and to mitigate these disparities by using concepts of cultural competency.
For Florida podiatrists, no more than 8 hours (20% of the hours of continuing education required per biennium) of home study programs may be credited toward the licensee’s biennial continuing education requirement for license renewal. A test must be completed and passed demonstrating competency in the topic taught in order to receive credit for the course.
Completion (Credits: 1.25) CME (Credits: 1)
Complete the 4 steps to earn your CE/CME credit:
This lecture has been approved for the PRESENT Podiatric Education Online curriculum by the Council of Teaching Hospitals Residency Education Review Committee.
Release Date: 02/09/2021 Expiration Date: 12/31/2023
PRESENT e-Learning Systems is approved by the Council on Podiatric Medical Education as a provider of continuing education in podiatric medicine. PRESENT e-Learning Systems has approved this activity for a maximum of 1 continuing education contact hours
Release Date: 02/09/2021 Expiration Date: 12/31/2022
To view Lectures online, the following specs are required:
It is the policy of PRESENT e-Learning Systems and it's accreditors to insure balance, independence, objectivity and scientific rigor in all its individually sponsored or jointly sponsored educational programs. All faculty participating in any PRESENT e-Learning Systems sponsored programs are expected to disclose to the program audience any real or apparent conflict(s) of interest that may have a direct bearing on the subject matter of the continuing education program. This pertains to relationships with pharmaceutical companies, biomedical device manufacturers, or other corporations whose products or services are related to the subject matter of the presentation topic. The intent of this policy is not to prevent a speaker with a potential conflict of interest from making a presentation. It is merely intended that any potential conflict should be identified openly so that the listeners may form their own judgments about the presentation with the full disclosure of the facts.---
Robert Smith has nothing to disclose.